Histogranin-Like Antinociceptive and Anti-Inflammatory Derivatives of o-Phenylenediamine and Benzimidazole

Journal of Pharmacology and Experimental Therapeutics

Volumn 309, Issue 1, 2004, Pages 146-155

  Le, Hoang Thanh ^a   Lemaire, Irma B ^a   Gilbert, Annie Kim ^a,b   Jolicoeur, François ^a,b   Yang, Lin ^a   Leduc, Natacha ^a   Lemaire, Simon ^a,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^c Faculty of Medicine   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 PHENYLENEDIAMINE; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; ANTINOCICEPTIVE AGENT; BENZIMIDAZOLE; BENZIMIDAZOLE DERIVATIVE; CYCLOOXYGENASE 2; HISTOGRANIN; N METHYL DEXTRO ASPARTIC ACID; N5 GUANIDINOPENTANAMIDYL 2 (4 HYDROXYBENZYL) 5 CARBOXYBENZIMIDAZOLE; N5 GUANIDINOPENTANAMIDYL 2 N (4 HYDROXYPHENYLACETYL)PHENYLENEDIAMINE; PEPTIDE; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; CONVULSION; DRUG POTENCY; HYPERALGESIA; LUNG ALVEOLUS MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; TAIL FLICK TEST; WRITHING TEST;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS; BENZIMIDAZOLES; CYCLOOXYGENASE 2; DINOPROSTONE; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; ISOENZYMES; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; PAIN; PHENYLENEDIAMINES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 1642289673     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.060772     Document Type: Article

References (50)

1. Akamatsu H, Fukase K, and Kusumoto S (2002) New efficient route for solid-phase synthesis of benzimidazole derivatives. J Comb Chem 4:475-483.
2. Balboni G, Salvadori S, Guerrini R, Negri L, Giannini E, Jinsmaa Y, Bryant SD, and Lazarus LH (2002) Potent delta-opioid receptor agonists containing the Dmt-Tic pharmacophore. J Med Chem 45:5556-5563.
3. Bean G (2002) an AM1 study of the effect of substituents on the bond dissociation energies of anilines, phenols and a-substituted toluenes. Tetrahedron 58:9941-9948.
4. Brase S, Gil C, and Knepper K (2002) The recent impact of solid-phase synthesis on medicinally relevant benzoannelated nitrogen heterocycles. Bioorg Med Chem 10:2415-2437.
5. Choi S-W, Elmaleh DR, Hanson RN, Shoup TM, and Fischman AJ (2002) Novel (bisarylmethoxy)butylpiperidine analogues as neurotransmitter transporter inhibitors with activity at dopamine receptor site. Bioorg Med Chem 10:4091-4102.
6. Clark WG, Vivonia CA, and Baxter CF (1988) Accurate freehand injection into the lateral brain ventricle of conscious mouse. J Appl Physiol 25:319-321.
7. D'Amour FE and Smith DL (1941) A method for determining loss of pain sensation. J Pharmacol Exp Ther 72:74-77.
8. Dubuisson D and Dennis SG (1977) The formalin test: a quantitative study of the analgesic effects of morphine, meperidine and brain stem stimulation in rats and cats. Pain 4:161-174.
9. Freshwater JD, Svensson CI, Malmberg AB, and Calcutt NA (2002) Elevated spinal cyclooxygenase and prostaglandin release during hyperalgesia in diabetic rats. Diabetes 51:2249-2255.
10. Gilbert AK and Franklin KB (2001) Characterization of the analgesic properties of nomifensine in rats. Pharmacol Biochem Behav 68:783-787.
11. 1]histogranin on complete Freund' adjuvant-induced hyperalgesic in rats. Pain 95:15-21.
12. 1]histogranin. Pharmacol Biochem Behav 62:67-74.
13. Heitsch H (2002) Non-peptide antagonists and agonists of the bradykinin B(2) receptor. Curr Med Chem 9:913-928.
14. Hruby VJ (2001) Design in topographical space of peptide and peptidomimetic ligands that affect behavior. A chemist's glimpse at the mind-body problem. Acc Chem Res 34:389-397.
15. Kaiser E, Colescott RL, Bossinger CD, and Cook PI (1970) Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal Biochem 34:595-598.
16. Khan S, Whelpton R, and Michael-Titus AT (1996) Evidence for modulatory effects of substance P fragments (1-4) and (8-11) on endogenous dopamine outflow in rat striatal slices. Neurosci Lett 205:33-36.
17. Kubo K, Kohara Y, Yoshimura Y, Inada Y, Shibouta Y, Furukawa Y, Kato T, Nishikawa K, and Naka T (1993) Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of potential prodrugs of benzimidazole-7-carboxylic acids. J Med Chem 36:2343-2349.
18. Le H-T, Lemaire I, Gilbert A-K, Jolicoeur F, and Lemaire S (2003) Bioactive peptidic analogues and cyclostereoisomers of the minimal antinociceptive histogranin fragment-(7-10). J Med Chem 46:3094-3101.
19. Lee J, Murray WV, and Rivero RA (1997) Solid phase synthesis of 3,4-disubstituted-7-carbamoyl-1,2,3,4-tetrahydroquinoxalin-2-ones. J Org Chem 62:3874-3879.
20. Leem JW, Hwang JH, Hwang SJ, Park H, Kim MK, and Choi Y (2001) The role of peripheral N-methyl-D-aspartate receptors in Freund's complete adjuvant induced mechanical hyperalgesia in rats. Neurosci Lett 297:155-158.
21. Lemaire I (1991) Selective differences in macrophage populations and monokine production in resolving pulmonary granuloma and fibrosis. Am J Pathol 138:487-495.
22. Lemaire S, Rogers C, Dumont M, Shukla VK, Lapierre C, Prasad JA, and Lemaire I (1995) Histogranin, a modified histone H-4 fragment endowed with N-methyl-D-aspartate antagonist and immunostimulatoty activities. Life Sci 56:1233-1241.
23. Lemaire S, Shukla VK, Rogers C, Ibrahim IH, Lapierre C, Parent P, and Dumont M (1993) Isolation and characterization of histogranin, a natural peptide with NMDA receptor antagonist activity. Eur J Pharmacol 245:247-256.
24. Liao S, Alfaro-Lopez J, Shenderovich MD, Hosohata K, Lin J, Li X, Stropova D, Davic P, Jernigan KA Porreca F, et al. (1998) De novo design, synthesis and biological activities of high-affinity and selective non-peptide agonist of the 8-opioid receptor. J Med Chem 41:4767-4776.
25. Lichfield JT and Wilcoxon FA (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99-113.
26. Lin YS, Gu Q, and Lee LY (2003) Activation of dopamine D2-like receptors attenuates pulmonary C-fiber hypersensitivity in rats. Am J Respir Crit Care Med 167:1096-1101.
27. Matsueda GR and Stewart JM (1981) A p-methylbenzhydrylamine resin for improved solid-phase synthesis of peptide amides. Peptides 2:45-50.
28. Menzler S, Bikker JA, and Horwell DC (1998) Synthesis of a non-peptide analogue of omega-conotoxin MVIIA. Tetrahedron Lett 39:7619-7622.
29. Menzler S, Bikker JA, Suman-Chauhan N, and Horwell DC (2000) Design and biological evaluation of non-peptide analogues of omega-conotoxin MVIIA. Bioorg Med Chem Lett 10:345-347.
30. Morales GA, Corbett JW, and DeGrado WF (1998) Solid-phase synthesis of benzopiperazinones. J Org Chem 63:1172-1177.
31. Morgan MJ and Franklin KB (1991) Dopamine receptor subtypes and formalin test analgesia. Pharmacol Biochem Behav 40:317-322.
32. Pataki G (1965) Revelation von peptiden und peptidderivaten, in Dunnschichtchromatographie in der aminosaure und Peptidchemie, pp 124-125, Walter de Gruyter, Berlin.
33. Prasad JA, Shukla VK, and Lemaire S (1995) Synthesis and biological activity of histogranin and related peptides. Can J Physiol Pharmacol 73:209-214.
34. Ren K, Williams GM, Hylden JL, Ruda MA, and Dubner R (1992) The intrathecal administration of excitatory amino acid receptor antagonists selectively attenuated carrageenan-induced behavioral hyperalgesia in rats. Eur J Pharmacol 219:235-243.
35. 1]histogranin binding sites in rat brain. J Pharmacol Exp Ther 267:350-356.
36. Ruan H and Lemaire S (2001) Interaction of histogranin and related peptides with dopamine D2 receptor in rat brain membranes. Synapse 39:270-274.
37. Ruan H, Prasad JA, and Lemaire S (2000) Non-opioid antinociceptive effects of supraspinal histogranin and related peptides: possible involvement of the dopamine D2 receptor. Pharmacol Biochem Behav 67:83-91.
38. Seybold VS, Jia YP, and Abrahams LG (2003) Cyclo-oxygenase-2 contributes to central sensitization in rats with peripheral inflammation. Pain 105:47-55.
39. 1]histogranin. Pharmacol Biochem Behav 50:49-54.
40. Siegan JB, Hama AT, and Sagen J (1997) Suppression of neuropathic pain by a naturally-derived peptide with NMDA antagonist activity. Brain Res 755:331-334.
41. Siegan JB and Sagen JA (1997) natural peptide with NMDA inhibitory activity reduces tonic pain in the formalin model. Neuroreport 8:1379-1381.
42. Smith JM, Gard J, Cummings W, Kanizsai A, and Krchnak A (1999) Necklace-coded polymer-supported combinatorial synthesis of 2-arylaminobenzimidazoles. J Comb Chem 1:368-370.
43. Tallarida RJ and Murray RB (1986) Manual of Pharmacological Calculations with Computer Programs, 2nd ed., Springer, New York.
44. Tao YX and Johns RA (2000) Activation of cGMP-dependent protein kinase alpha is required for N-methyl-D-aspartate- or nitric oxide-produced spinal thermal hyperalgesia. Eur J Pharmacol 392:141-145.
45. Tumelty D, Schwartz MK, Cao K, and Needelws MC (1999) Solid-phase synthesis of substituted benzimidazoles. Tetrahedron Lett 40:6185-6188.
46. Vourloumis D, Takahashi M, Simonsen KB, Ajida BE, Barluenga S, Winter GC, and Hermann T (2003) Solid-phase synthesis of benzimidazole libraries biased for RNA targets. Tetrahedron Lett 44:2807-2811.
47. Wegert S, Ossipov MH, Nichols ML, Bian D, Vanderah TW, Malan TP Jr, and Porreca F (1997) Differential activities of intrathecal MK-801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve-injured rats. Pain 71:57-64.
48. Wu Z and Ede NJ (2001) Solid-phase synthesis of quinoxalines on SynPhase™ lanterns. Tetrahedron Lett 42:115-118.
49. Yaksh TL, Dirig DM, Conway CM, Svensson C, Luo ZD, and Isakson PC (2001) The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1. J Neurosci 21:5847-5853.
50. Zarrinmayeh H, Zimmerman DM, Cantrell BE, Schober DA, Bruns RF, Gackenheimer SL, Ornstein PL, Hipskind PA, Britton TC, and Gehlert DR (1999) Structure-activity relationship of a series of diaminoalkyl substituted benzimidazole as neuropeptide Y Y1 receptor antagonists. Bioorg Med Chem Lett 9:647-652.